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Escherichia coliCytochrome bd ubiquinol oxidase uses the electron transport from ubiquinol to oxygen to establish
a proton gradient across the membrane. The enzyme complex consists of subunits CydA and B and
contains two b- and one d-type hemes as cofactors. Recently, it was proposed that a third subunit
named CydX is essential for the function of the complex. Here, we show that CydX is indeed a sub-
unit of puriﬁed Escherichia coli cytochrome bd oxidase and that the small protein is needed either
for the assembly or the stability of the active site di-heme center and, thus, is essential for oxidase
activity.
Structured summary of protein interactions:
cydA physically interacts with cydB by afﬁnity technology (View interaction)
cydA physically interacts with cydB by molecular sieving (View interaction)
cydB, cydA and cydX physically interact by molecular sieving (View interaction)
cydB, cydA, and cydX physically interacts by afﬁnity technology (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cytochrome bd ubiquinol oxidase is a terminal oxidase of pro-
karyotes, including several pathogens [1,2]. It is evolutionary not
related to the well-characterized members of the family of
heme-copper oxidases [3,4]. The enzyme oxidizes ubiquinol to ubi-
quinone and uses the electrons to reduce oxygen to water. The
reaction is electrogenic, contributing to the generation of a proton
motive force needed for other energy-consuming processes [5,6].
The enzyme complex has a high afﬁnity to oxygen and its genes
are therefore expressed under low oxygen tension [7]. Until
recently, it was generally accepted that the bd oxidase is made
up by two subunits called CydA and CydB. In Escherichia coli the
molecular mass of these subunits as deduced from the DNA
sequence is 58.2 and 42.5 kDa, respectively [8]. The oxidase
contains three non-covalently bound hemes as cofactors, namely
heme b558 functioning as electron acceptor for ubiquinol andhemes b595 and d forming a di-nuclear center to bind and reduce
oxygen [9,10]. All cofactors and the quinol binding site are presum-
ably located on CydA close to the periplasmic side of the
membrane [9,10]. Expression of cydA alone leads to the protein
with bound heme b558 demonstrating its tight binding to this
subunit [11].
Recently, it was reported that a short hypothetical gene located
at the 30-end of the bd oxidase operon and coding for a small pro-
tein is essential for the activity of cytochrome bd oxidase [12,13].
In E. coli, the gene was called ybgT and a homologous gene yccB
was found in the operon of the cytochrome bd-II oxidase [13].
Mutants lacking ybgT showed a reduced oxidase activity. The gene
was therefore proposed to be re-named to cydX and its paralog
yccB to appX, respectively [12,13]. Because CydX was co-puriﬁed
with CydA and CydB it was assumed to be part of the enzyme
complex [13]. Similar ﬁndings were reported with Brucella abortus
[12]. A deletion of cydX led to an increased sensitivity to H2O2, a de-
creased acid tolerance and an increase in sensitivity towards inhib-
itors of the respiratory chain [12]. It is discussed that CydX is
required for the proper function of bd oxidase by regulating its
assembly or its activity [12]. CydX belongs to the large group of
small proteins, whose genes are frequently overlooked in genome
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proteins. CydX contains 111 nucleotides encoding a protein with
a molecular mass of about 4.0 kDa. So far, cydX was only found
in proteobacteria. Secondary structure predictions imply that CydX
consists of a single transmembranous helix. A thorough analysis of
15 CydX variants demonstrated that none of its conserved amino
acids are indispensable for a fully functional cytochrome bd
oxidase [13]. Furthermore, it was shown that overexpression of
appX compensates the cydX deletion in E. coli [13]. Thus, CydX is
either a chaperone involved in the biogenesis of bd oxidase or it
is a subunit of the enzyme complex needed for its activity for
unknown reasons.
In this work we show, that CydX is a subunit of the enzyme
complex as it co-puriﬁes with CydAB. In addition, the lack of CydX
is associated with the loss of the di-heme active site of bd oxidase.
It was proposed that the di-heme center is located at the interface
of CydA and CydB [14]. Thus, CydX may stabilize the di-heme
center or it may play a role in its assembly.
2. Materials and methods
2.1. Construction of expression plasmids
Plasmid pET28b(+) was linearized using the primer pair pET28-
lin_fw and pET28-lin_rv while a linear fragment containing the tar-
get operon was ampliﬁed from E. coli C43(DE3) [15] genome using
the primer pair H1-cydA_fw and cydB-H2_rv (Tab. S1, Supplemen-
tary material). Both fragments were joined using the In-Fusion HD
Cloning Kit (Clontech) to yield the plasmid pET28 cydhisAB. The
plasmid pET28 cydAB was constructed from this vector by site-
directed mutagenesis removing the sequence encoding for a hexa-
histidine afﬁnity peptide and the thrombin cleavage site upstream
of cydA from pET28 cydhisAB. A linear fragment was ampliﬁed from
pET28 cydhisAB using the primer pair HindIII-cydA_fw and RBS-Hin-
dIII_rv (Tab. S1, Supplementary material) with subsequent self-
ligation of the introduced HindIII restriction site. The expression
plasmid pET28 cydAhisB was constructed by introducing the se-
quence encoding for a hexahistidine afﬁnity peptide at the 30-end
of cydA by ampliﬁcation of a linear fragment from pET28 cydAB
using the primer pair EcoRI-cydAhis_fw and cydA-EcoRI_rv (Tab.
S1, Supplementary material). The linear fragment was then circu-
larized by self-ligation of the EcoRI restriction site. The expression
plasmid pET28 cydAhisBX was constructed by introducing the cydX
gene downstream of cydB. The plasmid pET28 cydAhisB was linear-
ized using the primer pair pET28-cydAhisB-lin_fw and pET28-cydA-
hisB-lin_rv while a linear fragment containing the target gene was
ampliﬁed from E. coli C43(DE3) [15] genome using the primer pair
H3-cydX_fw and cydX-H4_rv (Tab. S1, Supplementary material).
Both fragments were joined using the In-Fusion HD Cloning Kit
(Clontech). To create the overexpression construct of cydABX con-
taining a Strep-tag II sequence at the 30-end of cydX, the cyd operon
including cydX was ampliﬁed from E. coli C43(DE3) [15] genomic
DNA using the primer pair cydX_fw and cydX_rv (Tab. S1, Supple-
mentary material). The operon was cloned into pET17b expression
vector and the nucleotide sequence encoding for the linker-Strep-
tag II sequence was then fused to the 30-end of cydX by site directed
mutagenesis using the primers cydX_fw, cydX_C1_rv, cydX_C2_rv
and cydX_strep_rv (Tab. S1, Supplementary material). The correct
sequence of the plasmids was inspected by DNA sequencing.
2.2. Expression strains and cell growth
E. coli strain CBO is a derivative of E. coli strain C43(DE3) [15] in
which both cydABX and appBCX have been deleted (designated:
C43(DE3) recA, cydABX, appBCX), leaving cytochrome bo3 as the
only respiratory oxygen reductase. CBO was transformed withpET28 cydhisAB, pET28 cydAhisB, pET28 cydAhisBX or pET17
cydABXStrep and grown aerobically in 1 L bafﬂed ﬂasks containing
400 ml LB-medium at 37 C. Gene expression was induced at an
OD600 of 0.4–0.6 by an addition of 0.4 mM isopropyl b-D-1-thioga-
lactopyranoside (IPTG). Cells were harvested in the late exponen-
tial phase and stored at 80 C.
2.3. Puriﬁcation of the cytochrome bd oxidase
All steps were carried out at 4 C. Frozen cells (15–20 g wet
weight) were resuspended in the 5-fold volume 50 mM 3-(N-mor-
pholino)propanesulfonic acid (MOPS), 100 mM NaCl, 1 mM phen-
ylmethylsulfonyl ﬂuoride (PMSF), pH 7.0 and disrupted by single
pass through a French pressure cell (SLM Alminco) at 17000 psi.
Cell debris were removed by centrifugation at 9500g for
20 min. Cytoplasmic membranes were sedimented by ultracentri-
fugation of the cleared lysate at 250000g for 75 min and subse-
quently resuspended in 50 mM MOPS, 100 mM NaCl, 0.5 mM
PMSF, pH 7.0 to a ﬁnal protein concentration of 10 mg/mL.
Membrane proteins were solubilized by incubating the mem-
brane suspension 1 h with 1% n-dodecyl b-D-maltoside (DDM)
(AppliChem). Unsolubilized material was sedimented by ultracen-
trifugation at 250000g for 15 min. The supernatant was applied
to a 15 ml ProBond Ni-IDA (Invitrogen) column pre-equilibrated
in 50 mM MOPS, 100 mM NaCl, 0.03 mM PMSF, 0.01% DDM,
pH 7.0 (buffer A) containing in addition 20 mM imidazole, with a
ﬂow rate of 1 ml/min. The column was washed with buffer A con-
taining 68 mM imidazole until baseline dropped to the original va-
lue. Bound proteins were eluted in a 40 ml linear gradient from 68
to 212 mM imidazole in buffer A. Peak fractions were pooled and
washed two times with buffer A in an Ultracel-100 K Amicon Ultra
centrifugal ﬁlter (Millipore) to minimize the imidazole concentra-
tion. The concentrated sample was submitted to size-exclusion
chromatography using a Superdex 200 16/600 pg column (GE
Healthcare) equilibrated in buffer A at a ﬂow rate of 0.5 ml/min.
For the puriﬁcation of Strep-tagged cytochrome bd, the superna-
tant containing solubilized membrane proteins was applied to a
2 ml Strep-tactin Superﬂow Plus column (QIAGEN) pre-equili-
brated with 50 mM sodium phosphate, 300 mM NaCl, 1 mM PMSF,
0.01% DDM, pH 8.0 (buffer B). The column was washed with 10 col-
umn volumes of buffer B. The Strep-tagged cytochrome bd was
eluted in buffer B containing 2.5 mM desthiobiotin, and the eluate
was concentrated in an Ultracel-50 K Amicon Ultra centrifugal
ﬁlter (Millipore).
2.4. Miscellaneous methods
UV/vis absorption spectra were recorded using a Tidas II Diode
Array Spectrometer (J&M Analytik AG) or an S1024DW Fiber Optic
Spectrometer (Ocean Optics). First, a spectrum of the air-oxidized
sample was recorded. The same sample was then reduced by an
addition of a few grains of dithionite and the spectrum was re-
corded again using the same set of parameters. The spectrum of
the oxidized sample was subtracted from that of the reduced sam-
ple. The (air-oxidized) and the (ferricyanide-oxidized) spectra
exhibited no difference. The purity of the preparations was
checked by a 4–20% (Biorad) or 16% polyacrylamide gel according
to Schägger [16] and subsequent Coomassie Brilliant Blue (CBB)
staining. To visualize hydrophobic protein bands, the CBB stained
gel was destained and used for silver-staining [17]. Protein bands
of interest were excised from the CBB-stained gel and submitted
to mass spectrometric analysis at the ZBSA (Dr. Sebastian Wiese,
Core Facility Proteomics, Institute of Biology, University of Frei-
burg) using a 6520 Q-TOF LC/MS system (Agilent Technologies).
Protein bands of CydA and CydB were digested using Trypsin, while
the CydX was digested with Elastase prior to analysis.
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3.1. Cell growth and puriﬁcation of cytochrome bd oxidase variants
with a tag on CydA
Strains CBO/pET28 cydhisAB, CBO/pET28 cydAhisB and CBO/pET28
cydAhisBX were grown under aerobic conditions in LB medium and
the oxidase genes were expressed by an addition of IPTG. The
growth of the strains was virtually identical (data not shown)
and yielded approximately 3–4 g cells (wet weight) per L medium.
The cytoplasmic membranes obtained from the strains showed
a signiﬁcant difference in color. Membranes isolated from strains
CBO/pET28 cydhisAB and CBO/pET28 cydAhisB were orange–red,
while those from strain CBO/pET28 cydAhisBX were green–brown.
To determine, which position of the afﬁnity-tag yields more assem-
bled protein, the detergent extract from strains CBO/pET28 cydhisAB
and CBO/pET28 cydAhisB were loaded on the afﬁnity chromatogra-Fig. 1. SDS–PAGE of the preparations of cytochrome bd oxidase. Lane 1 shows the
protein composition of the preparation from strain CBO/pET28 cydAhisB after
afﬁnity chromatography, lane 2 that from strain CBO/pET28 cydAhisBX after size-
exclusion chromatography. Each lane was loaded with 20 lg protein. Lane M shows
the bands of the protein marker standard. The gel stained with Coomassie Brilliant
Blue is marked with ‘CBB’ that stained with silver ‘Ag’. The subunits of the
cytochrome bd oxidase complex identiﬁed by mass spectrometry are marked by
arrows and attributed to their corresponding names.
Fig. 2. Secondary structure prediction of CydA, CydB and CydX and designation of peptid
the Protter online tool [20]. Peptides identiﬁed by mass spectrometry are shown in red.phy. For the CydhisAB variant, there was hardly any protein detect-
able in during the elution of bound proteins in the imidazole
gradient (Fig. S1, Supplementary material). The peak fractions of
the gradient yielded in total 0.5 mg protein. The UV/vis difference
spectrum of these fractions did not show any signiﬁcant absor-
bance (data not shown). The elution proﬁle afﬁnity chromatogra-
phy of the CydAhisB variant exhibited a very low yield of 1.4 mg
of a reddish protein eluting at 212 mM imidazole (Fig. S1, Supple-
mentary material). Subsequent size-exclusion chromatography of
the CydAhisB peak fractions exhibited a major peak at the exclusion
limit of the column indicating that the protein was degraded. The
shoulder at an elution volume of approximately 58 ml showed no
color and no signal in redox difference spectroscopy (Fig. S2, Sup-
plementary material). However, SDS–PAGE indicated that the frac-
tions after afﬁnity chromatography could contain CydA and CydB,
judged from the apparent molecular mass of the bands (Fig. 1).
The afﬁnity chromatography of the detergent extract from strain
CBO/pET28 cydAhisBX variant yielded 13.4 mg of a greenish–brown-
ish protein (Fig. S1, Supplementary material). Size-exclusion chro-
matography showed one major homogenous peak of absorbance at
an elution volume of 61.3 ml (Fig. S2, Supplementary material).
Calibration of the column by proteins of known molecular weight
revealed that this elution volume corresponds to a particle of
approximately 320 kDa, which in a good agreement with the
molecular mass of a CydAhisBX dimer in a DDM micelle. The pres-
ence of cydX in the expression plasmid resulted in a nearly ten-fold
enhanced yield in protein preparation. Because the C-terminal
position of the afﬁnity-tag on CydA is better suited for afﬁnity
chromatography than the N-terminus, we did not construct strain
CBO/pET28 cydhisABX.
3.2. Protein composition of preparations of the cytochrome bd oxidase
variants with a tag on CydA
The protein composition of the preparations of the bd oxidase
from strains CBO/pET28 cydAhisB and CBO/pET28 cydAhisBX were
analyzed by SDS–PAGE (Fig. 1). Gels stained with CBB showed that
the peak fractions from afﬁnity chromatography of the extract
from strain CBO/pET28 cydAhisB contained many proteins. How-
ever, two bands showed the expected apparent molecular masses
for CydA and B. Thus, amongst many other protein bands CydA
and CydB co-eluted from the afﬁnity chromatography. The gel of
the preparation of the bd oxidase from strain CBO/pET28 cydAhisBXes identiﬁed by mass spectrometry. Secondary structure prediction was done using
Fig. 4. Redox-difference spectra of the preparations of cytochrome bd oxidase
containing (red) or lacking (black) CydX. The (dithionite-reduced) minus (air-
oxidized) difference spectra of 50 lg protein in buffer A were recorded at room
temperature. The absorbance difference between 400 and 500 nm is scaled down to
one ﬁfth of intensity. The peak at approximately 655 nm (⁄) is an artifact of the
spectrometer.
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two major bands at approximately 54 and 30 kDa. Mass spectro-
metric analysis revealed that the 54 kDa band corresponds to CydA
(sequence coverage: 37%, overall score: 9865) and the 30 kDa to
CydB (sequence coverage: 11%, overall score: 3576). The relatively
low sequence coverage is typical for membrane proteins. No band
with an apparent molecular mass of 4 kDa was detectable in the
CBB-stained gel. However, silver staining revealed the presence
of several other bands (Fig. 1). Bands from hydrophobic proteins,
degradation products of CydA and CydB, were detected at about
20 and 8 kDa. Most interestingly, only the preparation of the bd
oxidase from strain CBO/pET28 cydAhisBX showed an additional
band at approximately 5 kDa (Fig. 1). This band corresponds to
CydX as revealed by mass spectrometry (sequence coverage: 67%,
overall score: 724). The fragments of CydA, CydB and CydX identi-
ﬁed by mass spectrometry are shown in red in Fig. 2. Although it is
hard to determine from silver stained gels it appears that CydA,
CydB and CydX are present in a stoichiometric amount.
Indeed, the presence of a third subunit with a low molecular
mass in the preparation of bd oxidase has been documented by
Miller & Gennis [18] for the ﬁrst time. A band close to the dye front
of the gel appeared after silver-staining. It was noted by the
authors that this band could not be separated from CydA and CydB
by various chromatographic steps [18].
3.3. Preparation of the cytochrome bd oxidase variant with a tag on
CydX
To check whether CydX is indeed a component of the bd oxidase
strain CBO transformed with pET17 cydABXStrep was grown and the
detergent extract was applied to a Strep-tactin column. The one-
step puriﬁcation with the protein containing an afﬁnity-tag on
CydX resulted in an enrichment of CydA and CydB in the eluate
(Fig. 3). Thus, the preparation with a tag on CydA contains beside
CydB also CydX and the preparation with a tag on CydX contains
CydAB. The preparation has a turnover of 1.200 electron/s and re-
mains more than 85% of its activity in the presence of 300 lM KCN
indicating the presence of a true bd oxidase.
3.4. UV/vis spectroscopic properties of preparations of the cytochrome
bd oxidase variants
The reduced-minus-oxidized difference spectrum of the prepa-
ration containing tagged-CydX showed the typical absorptions of bFig. 3. Expression and puriﬁcation of cytochrome bd oxidase with Strep-tagged CydX. (A
protein content (50 lg) of the eluate after Strep-tactin afﬁnity chromatography. (B) Red
CydX.and d hemes (Fig. 3). UV/vis reduced-minus-oxidized difference
spectra of the preparations with the tag on CydA differed from each
other (Fig. 4). The spectrum of the preparation of the CydAhisB
variant shows one single peak in the c-Soret region at 429.5 nm
corresponding to heme b558. This heme-group was also detected
by its absorbance at 531 and 562 nm. No signals from the other
heme-groups were detectable in this preparation. The signals from
b558 were also present in the spectrum of the preparation of the
CydAhisBX variant, but in addition the spectrum contained signals
from hemes b595 and d. The c-Soret region contains an additional
shoulder at about 440 nm caused by heme b595, while the signal
for heme d is superimposed with that of heme b558 at 430 nm. At
higher wavelengths additional signals at 594 and 629 nm from
hemes b595 and d, respectively, were identiﬁed. An additional neg-
ative signal, caused by the ferrous oxygenated form of heme d, is
seen at about 655 nm, but this signal is disturbed by an artifact
of the spectrometer.
These spectra show that the preparation of the CydAhisB variant
contains only heme b558. Contrary to this, the preparations of the
CydAhisBX and CydABXStrep variants are equipped with all cofactors) 4–20% SDS–PAGE stained with Coomassie Brilliant Blue G-250. Lane 1 shows the
uced-minus-oxidized difference spectrum of the cytochrome bd containing tagged-
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essential for the assembly and/or the stability of the di-heme active
site. Loss of CydX results in the absence of the di-heme center that
in turn causes the loss of enzymatic activity as described [12,13].
CydX is detected in the preparation of bd oxidase after deter-
gent extraction and two chromatographic steps in stoichiometric
amounts, thus, it is the third subunit of the cytochrome bd oxidase,
at least in proteobacteria. Secondary structures predictions of CydA
revealed the presence of a hydrophilic loop connecting transmem-
brane helices VI and VII (Fig. 2). The so-called ‘‘Q-loop’’ is protrud-
ing into the periplasm and was proposed to be part of the
ubiquinol binding site [8]. From sequence alignments it was con-
cluded that CydA from proteobacteria contains an insert of up to
65 amino acids at the C-terminal end of the Q-loop, which is lack-
ing in the majority of CydA subunits from other organisms. As cydX
is so far only found in proteobacteria it might be possible, that it
interacts with the extended Q-loop of bd oxidase in these species.
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